$3.28
0.196.15%
Last update: Nov 11, 4:00 PM
Intensity Therapeutics Inc
INTSNASDAQ
Intensity Therapeutics fell 74.4% from $12.80 to $3.28, behind the S&P 500's +11.2%. Its worst day was Feb 13 (−32.6%), and its low came Nov 6 at $3.03.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Intensity Therapeutics closed at its highest level of the year, 15.2% above where the year started.
+7.3% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
Intensity Therapeutics shares fell 32.6%, while the S&P 500 rose 0.1%.
−32.6%, the year's worst day · S&P 500 +0.1%
Intensity Therapeutics shares rose 16.4%, while the S&P 500 rose 0.7%.
+16.4%, the year's best day · S&P 500 +0.7%
EPS of $-1.31 missed the $-1.29 estimate on $0.00 revenue.
−5.8% · S&P 500 −0.3%
EPS of $-0.96 beat the $-1.14 estimate on $0.00 revenue.
−0.4% · S&P 500 +0.8%
EPS of $-1.11 missed the $-0.78 estimate on $0.00 revenue.
−2.1% · S&P 500 −0.3%
Intensity Therapeutics shares rose 16.2%, while the S&P 500 fell 0.8%.
+16.2% · S&P 500 −0.8%
EPS of $-1.09 missed the $-0.98 estimate on $0.00 revenue.
−13.2% · S&P 500 −4.4%
Where it ended: a close of $3.28 on Nov 11, 2026.
Nothing in the past 12 months.
All INTS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INTS and SPY from Benzinga historical bars. Not investment advice.
